Susanne Temming
Papers
3
Total Citations
109
H-Index
3
About
Susanne Temming is a leading researcher in the intersection of radiation oncology and medical imaging, with a primary focus on lung cancer treatment. Her work centers on improving outcomes for patients with inoperable early-stage non-small-cell lung cancer (NSCLC) through the refinement of robotic stereotactic body radiation therapy (SBRT). Temming’s most significant contributions lie in the application of radiomics—the high-throughput extraction of quantitative features from medical images—to predict both treatment efficacy and toxicity. Her landmark 2019 study, cited 44 times, demonstrated that radiomic analysis of planning CT scans could forecast radiation-induced lung injury and overall outcomes in NSCLC patients. She further advanced this field with a 2021 multi-institutional study (29 citations) that validated these predictive models across independent patient cohorts, enhancing their clinical reliability. Additionally, her 2017 work on risk-adapted SBRT (36 citations) established a framework for personalizing radiation doses to maximize tumor control while minimizing side effects. Through these efforts, Temming has pioneered a data-driven approach to lung cancer radiotherapy, enabling more precise, patient-specific treatment planning that promises to reduce complications and improve survival rates.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3